Analyst: Polaris stock dip an 'overreaction'
Wedbush analyst James Hardiman called the broad sell-off in the stock market over the past six weeks indiscriminate. To him, the sell-off has been far from uniform and has created situations where some fundamentally sound companies in his coverage universe — power sports, cruise lines and amusement park industries — have been bid down too much, making them attractive to pick up.
According to Hardiman's research note he put out last week: "Brunswick Corp. and Polaris Industries Inc. are the second- and third-cheapest names in our coverage, which are glaring overreactions in our view, and we believe they represent excellent ideas as investors take inventory of the recent carnage and look to buy."
Patrick Kennedy
Medtronic has options for using freed up cash
Medtronic PLC has freed up $9.3 billion in cash as part of an internal restructuring, according to a Securities and Exchange Commission filing last week.
Leerink analyst Danielle Antalffy wrote in a research note that Medtronic could put that extra cash to work by paying down long-term debt or rewarding shareholders through increased dividends and stock repurchases.
With the additional cash freed up, Medtronic has $12.5 billion in total cash that also could be used for acquisitions. "We would expect Medtronic to be more active in M&A over the next 12 to 18 months now with access to significantly more cash on hand," Antalffy noted.